Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 10 of 29
-
Why all WTO members should back the TRIPS waiver proposal
There is evidence to show that an equitable roll-out of COVID-19 vaccines globally would dramatically reduce the loss of life....
-
GALLERY: International Women’s Day 2021
Around this time last year, before many countries went into their first COVID-19 related lockdown, Make Medicines Affordable met with...
-
‘Held to ransom’: Pfizer demands governments gamble with state assets to secure vaccine deal
Pfizer has been accused of “bullying” Latin American governments in COVID-19 vaccine negotiations and has asked some countries to put...
-
The next COVID-19 crisis: A vaccine apartheid endangering us all
The West bought billions of vaccines fast and cheap, leaving poorer nations waiting longer and paying more. Published by The...
-
Civil society files lawsuit against Thai Department of Intellectual Property as “failure to reject TB patent is unlawful”
Translated from the original press release published in Thai, by The Standard and Prachathai. On 2 February 2021, a civil...
-
“No more delay – reject patent request for potential COVID-19 drug” urges Thai civil society
Japanese company Fujifilm-Toyama has filed for patents on favipiravir in Thailand. Favipiravir is an antiviral drug which has been used...
-
Pan-genotypic Hep-C drug added to Thai health system
The first pan-genotypic Hepatitis C drug, which can be prescribed without the requirement for expensive and limited testing to determine...
-
Activism is “keeping your feet on the ground”
Interviewed by Gemma Taylor. “I am from a traditional family in Manipur. The way we were brought up was to...
-
Getting India’s struggling Hep-C services re-open during COVID-19
For the estimated 6-12 million people living with Hepatitis C in India, access to treatment was already way below the...
-
Russian government issues its first health-related compulsory license
A new year signals a new approach to access to medicines in the Russian Federation. Remdesivir, a drug patented by...
-
New data demonstrates the impact of patents in Ukraine
2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
-
Natalia: “You only live once (YOLO), make it positive!”
An interview with Natalia, a former team member and friend of 100% LIFE, our campaign partner in Ukraine, and life-long...